NO RECOVERY, NO FEE
(855) 339-8879
FREE CONSULTATION

Generic Actos on the rise, Will Result in More Bladder Cancer Cases


Generic Actos on the rise, Will Result in More Bladder Cancer CasesWatson Pharmaceuticals won a decision against the United States Food and Drug Administration for its right to sell the generic version of the drug Actos (pioglitazone).  This follows an August decision by the FDA which approved generic versions of the type 2 diabetes drug.  Watson follows the path of Mylan Pharmaceuticals, Ranbaxy Laboratories and Teva Pharmaceuticals as the other manufacturers selling generic forms of Actos. Actos was initially introduced in 1999 by Takeda Pharmaceuticals, and was initially hailed as powerful drug against type 2 diabetes.  However, soon after its inception, individuals taking the drug began experiencing harmful side effects including bone fractures, heart complications and other severe damages. Most detrimental however, are the mounting studies that suggest that Actos, and other medications containing pioglitazone increases the risk of bladder cancer by up to 80 percent. This following a 2007 decision by the FDA to include a “black box” warning on all boxes of Actos that indicate the drug increases the risk of congestive heart failure by as much 30 percent.  In fact, experts predict that lawsuits relating to bladder cancer and the use of Actos may reach as much as 10,000 in the next few years. In 2011, Actos had sales of $3.4 billion in the United States alone, a number that is sure to decline with the introduction of new generic pills on to the market.

Over $500 Million Recovered
for Our Clients

Learn More

YOU Deserve the Best
Free Case Review 24/7
You Don’t Pay unless we win
Call 855.385.2529





  • This field is for validation purposes and should be left unchanged.

By submitting this form, you agree to receive telephone calls and text messages at anytime, which include hours outside of business hours (8:00 am PST – 9:00 pm PST). This is so that we may reach you as soon as possible in order to consult on your potential case.

ultimate guide uber lyft accidents

Featured Lawyers


farid-medium

Farid Yaghoubtil, Esq.

sal-medium

Salar Hendizadeh, Esq.

Nina Sargsyan, Esq.

dan-medium

Daniel Azizi, Esq.

 

 

Free Case Review 24/7
You Don’t Pay Unless You Win
Call 855.385.2529


  • This field is for validation purposes and should be left unchanged.

By submitting this form, you agree to receive telephone calls and text messages at anytime, which include hours outside of business hours (8:00 am PST – 9:00 pm PST). This is so that we may reach you as soon as possible in order to consult on your potential case.

Address:

LOS ANGELES OFFICE
910 S Broadway, Suite 600
Los Angeles, CA 90016
(855) 339-8879

LOS ANGELES OFFICE
4113 Clinton Ave,
Los Angeles, CA 90004
(855) 339-8879

BAKERSFIELD OFFICE
2005, Eye Street, Suite 4
Bakersfield, CA 93301
(661) 219-7455

MODESTO OFFICE
3430 Tully Road
Modesto, California 95350
(209) 353-4493

ORANGE COUNTY OFFICE
2372 Morse Ave.
Irvine, California 92614
(949) 627-8725

SAN DIEGO OFFICE
01 West Broadway
San Diego, California 92101
(619) 413-0161

OXNARD OFFICE
105 N Oxnard Blvd,
Oxnard, CA 93030
(805) 263-4423

SAN FRANCISCO OFFICE
1 Sansome St. Suite 3500-11
San Francisco, California 94104
650-651-5006

VENTURA OFFICE
701 E Santa Clara St
Ventura, California 95816
805-292-0367

INLAND EMPIRE OFFICE
7121 Magnolia Ave
Riverside, California 92504
909-340-3929

VICTORVILLE OFFICE
13782 Bear Valley Rd.
Victorville, California 92392
(760) 563-4384

FRESNO OFFICE
5588 N Palm Ave
Fresno, California 93704
(559) 556-0227

SAN FRANCISCO OFFICE
388 Market St #1300
San Francisco, California 94111
(415) 362-6079

SACRAMENTO OFFICE
1601 Alhambra Blvd
Sacramento, California 95816
(916) 931-1965

SAN FRANCISCO OFFICE
1 Sansome St. Suite 3500-11
San Francisco, California 94104
(650) 651-5006

MIAMI OFFICE
11900 Biscayne Blvd North
Miami, Florida 33154

EL PASO OFFICE
4600 Alabama St #C
El Paso, Texas 79930
(915) 201-3865


The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.
Follow Us